期刊文献+

冠状动脉内窥镜的临床应用 被引量:1

下载PDF
导出
摘要 冠状动脉内窥镜通过对冠脉内腔的直视,对于粥样斑块、血栓及夹层等诊断可靠。根据血栓的颜色可间接推定其与病因间的关系。目前已广泛用于冠脉成形术疗效评价等方面。
出处 《心血管病学进展》 CAS 1998年第1期16-17,共2页 Advances in Cardiovascular Diseases
  • 相关文献

同被引文献32

  • 1Miercs JH. Review of the American Heart Association's guidelines for cardiovascular disease prevention in women[J]. Heart, 2006, 92 Suppl 3: iiil0-13. DOI: 10.1136/hrt.2005.070326.
  • 2Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein Ⅱ b/Ⅲ a inhibitor tirofiban[J]. N Engl J Med, 2001, 344(25): 1879-1887. DOI: 10. 1056/NEJM200106213442501.
  • 3Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization[J]. N Engl J Med, 2002, 346(23): 1773- 1780. DOI:10.10561NEJMoaO12843.
  • 4Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure[J]. J Am Coil Cardiol, 2012, 59(23): 2051-2057. DOI: 10.1016/j.jaee.2011.10.909.
  • 5Hou J, Qi H, Zhang M, et al. Development of lipid-rich plaque inside bare metal stent: possible mechanism of late stent thrombosis? An optical coherence tomogrsphy study[J]. Heart, 2010, 96(15): 1187-1190. DOh 10.1 136/hrt.2010.194381.
  • 6Nakazawa G, Otsuka F, Nakano M, et al. Thepathology of neoatheroselerosis in human coronary implants bare-metal and drugeluting stents[ J]. J Am Coll Cardiol, 2011, 57(11): 1314-1322. DOI: 10.1016/j.jace.2011.01.011.
  • 7Taniwaki M, Windeeker S, Zaugg S, et al. The association between in-stent neoatheroselerosis and native coronary artery disease progression: a /ong-term angiographie and optical coherence tomography cohort study[J]. Eur Heart J, 2015, 36(32): 2167-2176. DOI: 10.1093/eurheartj/ehv227.
  • 8Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview 9f histopathologic findings and implications for intravascular imaging assessment[J]. Eur Heart J, 2015, 36(32): 2147-2159. DOI: 10.1093/eurheartj/ehv205.
  • 9Otsuka F, Vorpabl M, Nakano M, et al. Pathology of second- generation everolimus-eluting stents versus first-generation sirolimus- and Paclitaxel-eluting stents in humans[J]. Circulation,2014, 129(2): 211-223. DOI: 10.1161/CIRCULATIONAHA. 113. 001790.
  • 10Kim C, Kim BK, Lee SY, et al. Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation[J]. Am Heart J, 2015, 170(3): 591-597. DOI: 10.1016/ j.ahj.2015.06.005.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部